The efficacy and safety of intravenous chlorpromazine treatment for sleep disturbance in patients with incurable cancer, with oral administration difficulty: a 1-week, prospective observational study | Zendy

Ryohei Fujii | Zendy; Hideaki Hasuo | Zendy; Hiroko Sakuma | Zendy; Miyuki Okada | Zendy; Kazuki Uchitani | Zendy

Open Access

The efficacy and safety of intravenous chlorpromazine treatment for sleep disturbance in patients with incurable cancer, with oral administration difficulty: a 1-week, prospective observational study

Author(s) -

Ryohei Fujii,

Hideaki Hasuo,

Hiroko Sakuma,

Miyuki Okada,

Kazuki Uchitani

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-21-948

Subject(s) - medicine , observational study , chlorpromazine , intensive care medicine , sleep disorder , administration (probate law) , cancer , disturbance (geology) , anesthesia , pharmacology , insomnia , paleontology , political science , law , biology

Sleep disturbance is a common psychiatric disorder in patients with cancer. However, many patients with incurable cancer have difficulty receiving oral administrations, which limits treatment options during disease progression. The aim of the present study was to assess the efficacy and safety of intravenous chlorpromazine treatment for sleep disturbances in patients with incurable cancer, with oral administration difficulty.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research